Catalog Number 328468 |
Device Problem
Misconnection (1399)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 06/15/2022 |
Event Type
malfunction
|
Event Description
|
It was reported that the bd insulin syringe with the bd ultra-fine¿ needle hub separated and remained in the shield.This complaint was created to capture the 2nd of 2 related incidents.The following information was provided by the initial reporter: "needle hub separated and stayed inside of the shield.".
|
|
Manufacturer Narrative
|
Date of event: unknown.The date received by manufacturer has been used for this field.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
|
Manufacturer Narrative
|
The following fields were updated due to additional information: d.9.Device available for eval: yes.D.9.Returned to manufacturer on: 18-jul-2022.H.6.Investigation summary: customer returned one syringe in a polybag labeled for 0.5ml, 8mm, 31 gauge syringes from lot 9343403, and two loose syringes.The syringe from lot 9343403 had its needle shield and hub separate from the barrel.The hub has become lodged inside the shield.There is no damage to either the connector at the distal tip of the barrel or its respective needle hub.No signs of use and no other defects found.The remaining syringes were returned fully intact outside of both polybags.A needle shield pull force test was performed on each of these syringes.The needle shields required 2.28 lbs and 1.97 lb of force to be removed.Removing the needle shields found that the hubs were properly attached to the barrel of the syringes.The specification states that all pull forces within the range of 0.85 lbs to 5.95 lbs are acceptable.No defects found to these two syringes.A review of the device history record was completed for batch# 9343403.All inspections and challenges were performed per the applicable operations qc specifications.Based on the samples received, embecta was able to confirm the customer¿s indicated failure of needle hub separation.A definitive root cause cannot be determined.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.Our business team regularly reviews the collected data for identification of emerging trends.
|
|
Event Description
|
It was reported that the bd insulin syringe with the bd ultra-fine¿ needle hub separated and remained in the shield.This complaint was created to capture the 2nd of 2 related incidents.The following information was provided by the initial reporter: "needle hub separated and stayed inside of the shield.".
|
|
Search Alerts/Recalls
|